Brief: Kiniksa Pharmaceuticals Reports First Quarter 2023 Financial Results And Recent Portfolio Execution

Kiniksa Pharmaceuticals International

02/05/2023 12:31

May 2 (Reuters) - Kiniksa Pharmaceuticals Ltd  KNSA.O :
    * KINIKSA PHARMACEUTICALS REPORTS FIRST QUARTER 2023
FINANCIAL
RESULTS AND RECENT PORTFOLIO EXECUTION
    * KINIKSA PHARMACEUTICALS LTD - CASH RESERVES NOW EXPECTED
TO FUND
OPERATIONS INTO AT LEAST 2026
    * KINIKSA PHARMACEUTICALS LTD - NOW EXPECTS ARCALYST NET
PRODUCT
REVENUE FOR FULL-YEAR 2023 OF BETWEEN $200 MILLION AND $215
MILLION

Source text for Eikon:  ID:nGNX8QMJ3R 
Further company coverage:  KNSA.O 

 ((Reuters.Briefs@thomsonreuters.com;))